Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
US-9,540,420 Mucosal vaccines
A mucosal vaccine producing an antigen-specific mucosal IgA and a blood IgG in the levels capable of exerting an effective immune induction and an...
US-9,540,419 Anti-inflammatory peptides and composition comprising the same
A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned...
US-9,540,418 Polypeptide specifically binding to rare earth nanoparticles and use thereof
The present invention provides a polypeptide able to specifically bind to rare-earth nanoparticles and the use thereof. The polypeptide comprises an amino acid...
US-9,540,417 Compositions and methods for treating ischemia and ischemia-reperfusion injury
The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula I: ##STR00001## and methods of using...
US-9,540,416 Purification process
The present disclosure concerns methods for producing purified saponins, such as QS-21, which reduces the number of necessary lyophilization cycles to one by a...
US-9,540,415 Inhibitors of the farnesoid X receptor and uses in medicine
Disclosed are inhibitors of the farnesoid X receptor, for example of formula (I), wherein R.sup.1, R.sup.2, R.sup.4, X, Y, Z, m, and n are as defined herein,...
US-9,540,414 TGR5 modulators and methods of use thereof
The invention relates to compounds of Formula A: ##STR00001## or a salt, solvate, or hydrate thereof. The compounds of formula A are TGR5 modulators useful...
US-9,540,413 Method for monofluoromethylation of organic substrates to prepare biologically active organic compounds
Described herein is a process for the preparation of monofluoromethylated organic biologically active compounds using monofluoromethylated reagents. Fluticasone...
US-9,540,412 Methods of preparing targeted aptamer prodrugs
The present invention provides methods of preparing an oligonucleotide, nucleoside or nucleoside analog for selective introduction into a subject's cells, the...
US-9,540,411 HCV polymerase inhibitors
The invention provides compounds of the formula: ##STR00001## wherein B is a nucleobase selected from the groups (a) to (d): ##STR00002## and the other...
US-9,540,410 Gemcitabine prodrugs and uses thereof
The present invention provides compounds according to formula I: ##STR00001## and pharmaceutically acceptable salts thereof. For compounds of formula I,...
US-9,540,409 Synthetic amphiphiles for membrane protein manipulation
The invention provides amphiphilic compounds and methods for manipulating membrane proteins. Compounds of the invention, for example, the compounds of Formulas...
US-9,540,408 Cobalt precursors for low temperature ALD or CVD of cobalt-based thin films
Cobalt silylamide and cobalt carbonyl precursors are described, which are usefully employed in vapor deposition processes, such as chemical vapor deposition and...
US-9,540,407 Phospholipid drug analogs
Provided in some embodiments are compositions comprising a compound having a structure according to Formula A or Formula B: ##STR00001## or a pharmaceutically...
US-9,540,406 Process for fosaprepitant
The present invention provides a novel process for reducing palladium content in fosaprepitant dimeglumine.
US-9,540,405 Diaminophenothiazinium derivatives for labelling biomolecules, method and substrate for labelling...
The present invention relates to diaminophenothiazinium derivatives of formula (I); in which R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and X.sup.-...
US-9,540,404 Fluorinated ether compound, fluorinated ether composition and coating liquid, and substrate having...
To provide a fluorinated ether compound, a fluorinated ether composition and a coating liquid, whereby it is possible to form a surface-treated layer which has...
US-9,540,403 Bonding method, bondability improving agent, surface modification method, surface modifying agent, and novel...
To provide a technique by which an --OH group can be effectively formed on a material surface for the purpose of making the material suitable for bonding (for...
US-9,540,402 Covalent tethering of functional groups to proteins
A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the...
US-9,540,401 Method for producing alkyl-indium compounds and the use thereof
The invention relates to a method for the cost-effective and environmentally friendly production of dialkyl indium chloride in high yield and with high...
US-9,540,400 Compounds as diacylglycerol acyltransferase inhibitors
This invention relates to novel compounds which are inhibitors of acyl coenzymeA: diacylglycerol acyltransferase 1 (DGAT-1), to pharmaceutical compositions...
US-9,540,399 Quinolone derivatives
The invention relates to antibacterial compounds of formula I ##STR00001## wherein R.sup.1, U, V and A are as defined in the description, to pharmaceutical...
US-9,540,398 3-(1h-imidazo[4,5-C]pyridin-2-yl)-1h-pyrazolo[3,4-C]pyridine and therapeutic uses thereof
Azaindazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an azaindazole...
US-9,540,397 BACE1 inhibitors
The present invention provides a compound of formula I, having BACE1 inhibitory activity, their manufacture, pharmaceutical compositions containing them and...
US-9,540,396 6-arylamino pyridone carboxamide as MEK inhibitors
The invention provides novel substituted 6-arylamino pyridone carboxamides represented by Formula I, or a pharmaceutically acceptable salt, solvate, poly-morph,...
US-9,540,395 Histone deacetylase inhibitors
This invention relates to generally inhibiting histone deacetylase (HDAC) enzymes (e.g., HDAC1, HDAC2, and HDAC3).
US-9,540,394 Compounds and methods for treating bacterial infections
Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed. ...
US-9,540,393 Inhibitors of human immunodeficiency virus replication
The disclosure generally relates to compounds of formula (I), including compositions and methods for treating human immunodeficiency virus (HIV) infection. The...
US-9,540,392 Thienopyrimidines
The present invention relates to substituted thienopyrimidine compounds of general formula (I) as described and defined herein, to methods of preparing said...
US-9,540,391 Isomannide derivatives as inhibitors of soluble epoxide hydrolase
The present invention relates to compounds of the formula (I), wherein R1, R11, R12 and X have the meanings indicated in the claims. The compounds of formula I...
US-9,540,390 Method for manufacturing 1,4:3,6-dianhydrohexitol di(alkyl carbonate)s
The present invention relates to a process for the manufacturing of pure and substantially oligomers-free 1,4:3,6-dianhydrohexitol di(alkyl carbonate)s which...
US-9,540,389 Antimicrobial potentiators
Novel compounds are disclosed having the structure of Formula I: ##STR00001## wherein, n is an integer from 1 to 5; X is --CN, --F, --Cl, --Br, --I,...
US-9,540,388 P2X7 modulators
The present invention is directed to a compound of Formula (I): wherein: The present invention is directed to a compound of Formula (I): wherein: .cndot.n is an...
US-9,540,387 Substituted imidazo[1,2-d]pyrrolo[1,2-d]pyrazines for treating respiratory syncytial virus infections
The present invention relates to compounds of formula (I) ##STR00001## its salts, isomers or prodrugs thereof useful in the treatment of viral infections, in...
US-9,540,386 Crystals of dispiropyrrolidine derivatives
Crystals of a dispiropyrrolidine compound or a salt thereof which inhibits the action of Mdm2 are provided. The present invention provides crystals of ...
US-9,540,385 Pyrrolopyrimidine compounds as kinase inhibitors
Disclosed herein are pyrrolo[2,3-d]pyrimidine compounds that form covalent bonds with Bruton's tyrosine kinase (Btk). Also described are irreversible inhibitors...
US-9,540,384 Pyrrolidino heterocycles
The invention relates to compounds of formula I ##STR00001## wherein A.sub.1, A.sub.2, A.sub.3, B, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are as defined in...
US-9,540,383 Pyrrolopyrimidines as therapeutic agents for the treatment of diseases
Compounds of formula (I) and salts thereof: ##STR00001## wherein R.sub.1 is n-C.sub.4-6alkyl or C.sub.1-2alkoxyC.sub.1-2alkyl-; R.sub.2 is hydrogen or methyl;...
US-9,540,382 Crystalline forms of a Bruton's tyrosine kinase inhibitor
Described herein is the Bruton's tyrosine kinase (Btk) inhibitor 1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)pi- ...
US-9,540,381 Anti-angiogenesis compound, intermediate and use thereof
Disclosed are an anti-abnormal proliferation of angiogenesis compound represented by formula I, use and intermediate thereof. The compound has good effect...
US-9,540,380 Imidazotriazinone compounds
The present invention provides imidazotriazinone compounds which are inhibitors of phosphodiesterase 9. The present invention further provides processes,...
US-9,540,379 (1,2,4)triazolo[4,3-A]quinoxaline derivatives as inhibitors of phosphodiesterases
The invention relates to (1,2,4)triazolo[4,3-a]quinoxaline derivatives which are inhibitors of phosphodiesterase 2 and/or 10, useful in treating central nervous...
US-9,540,378 Composition comprising purine derivatives or salt thereof for preventing or treating atopic dermatitis
The present invention provides a pharmaceutical composition for preventing or treating atopic dermatitis comprising 2-amino-1,9-dimethylpurin-6-one or its...
US-9,540,377 2,6,7,8 substituted purines as HDM2 inhibitors
The present invention provides 2,6,7,8 Substituted Purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are...
US-9,540,376 Hexahydrodiazepinoquinolines carrying a substituted alkyl radical
The present invention relates to tricyclic hexahydrodiazepinoquinolines, such as compounds of formula (I), carrying a substituted alkyl radical, to a method for...
US-9,540,375 Kappa opioid receptor effectors and uses thereof
The present invention is a selective kappa opioid receptor effector, or a pharmaceutically acceptable salt thereof, useful for treating ethanol use disorder...
US-9,540,374 Nitrogen-containing heterocyclic compounds and organic electronic device comprising the same
The present invention provides a nitrogen-containing heterocyclic compound and an organic electronic device including the same.
US-9,540,373 Substituted spirocycles
This invention relates to a compound of formula I ##STR00001## wherein A and Cy have one of the meanings as indicated in the specification and their use as...
US-9,540,372 Pyrido[2,3-b]pyrazin-8-substituted compounds and their use
The present invention pertains generally to the field of therapeutic compounds for treating proliferative disorders, cancer, etc., and more specifically to...
US-9,540,371 Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and...
In one aspect, the invention relates to 3-benzylquinazolin-4(3H)-one analogs, derivatives thereof, and related compounds, which are useful as positive...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.